Hyperphagia in Children with Prader-Willi Syndrome

Primary Genetic Cause: Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is the most important genetic cause of hyperphagia in children, occurring in approximately 1 in 15,000 to 1 in 25,000 live births, and should be the primary diagnostic consideration when evaluating a child with excessive appetite, particularly when accompanied by early hypotonia, developmental delay, and rapid weight gain, according to the American Academy of Pediatrics 1, 2
PWS accounts for the most common syndromic cause of childhood hyperphagia, affecting both genders equally across all geographic regions, as stated by the American Academy of Pediatrics 1

The genetic basis of PWS involves three primary mechanisms: paternal deletion (approximately 70% of cases), maternal uniparental disomy (approximately 20% of cases), and imprinting defects (rare but important), as reported by the American Academy of Pediatrics 3, 4

The hyperphagia in PWS results from hypothalamic dysfunction affecting the orexin-hormone system and impaired neural response to food intake, leading to inability to regulate food consumption in line with energy needs, according to the American Academy of Sleep Medicine 5

Children with PWS show significant hypotonia with poor suck and difficulty with weight gain from birth to 2 years, excessive sleepiness with failure to awaken for feeding, and hypogonadism, as stated by the American Academy of Pediatrics 1, 6, 5
Between ages 2-6 years, congenital hypotonia with history of poor suck persists, global developmental delay becomes apparent, and transition to hyperphagia begins, according to the American Academy of Pediatrics 1, 2
From ages 6-12 years, excessive eating (hyperphagia) with obsession with food becomes the dominant feature, central obesity develops, and impaired satiety for food with rapid weight gain occurs, as reported by the American Academy of Pediatrics 1, 2

When hyperphagia is identified in a child, immediately consider PWS and proceed with methylation analysis of chromosome 15q11-q13 as the first-line diagnostic test, particularly when hyperphagia occurs with history of neonatal hypotonia and feeding difficulties, global developmental delay, rapid weight gain with central obesity, poor linear growth despite excessive food intake, and hypogonadism, according to the American Academy of Pediatrics 1, 2, 4

Hyperphagia in PWS directly causes life-threatening complications independent of obesity, including massive obesity with associated diabetes, obstructive sleep apnea, right-sided heart failure, and death typically occurs in the fourth decade without intervention, as stated by the American Academy of Pediatrics 2
However, with meticulous weight control, individuals with PWS can remain healthy into their seventh decade, according to the American Academy of Pediatrics 2

The most dangerous error is failing to recognize that hyperphagia in PWS represents a neurological inability to feel satiety, not a behavioral choice, and requires environmental controls rather than behavioral punishment alone, as reported by the American Academy of Pediatrics 7

The American Academy of Pediatrics recommends strict environmental control of food access and caloric restriction to approximately 60% of normal requirements for individuals with Prader-Willi syndrome, combined with growth hormone therapy and multidisciplinary management 8
Monitor weight frequently and adjust caloric intake to maintain appropriate growth despite poor feeding in infancy, using specialized feeding systems and considering nasogastric tube feeding if necessary 8
Restrict calories to 60% of age-matched requirements, approximately 800-1200 kcal/day, and work with a dietitian to ensure adequate essential nutrients despite severe caloric restriction 8

The American Academy of Sleep Medicine and the American Academy of Pediatrics recommend growth hormone therapy as the only FDA-approved treatment for Prader-Willi syndrome, which improves lean body mass, motor development, and normalizes body habitus 8, 9
Consider sleep study prior to initiation of growth hormone therapy, though testing should not delay treatment 9, 10

The American Academy of Sleep Medicine recommends evaluating individuals with Prader-Willi syndrome annually for sleep-disordered breathing, excessive daytime sleepiness, narcolepsy, cataplexy, and insomnia, and considering polysomnography when weight changes rapidly or behavior worsens 9, 10
Include sleep specialists in the multidisciplinary team to address sleep disorders that contribute to food-seeking behaviors and behavioral problems 9, 10

The American Academy of Pediatrics recommends evaluating individuals with Prader-Willi syndrome for hypothalamic-pituitary axis dysfunction beyond growth hormone deficiency, including measuring early-morning ACTH and cortisol levels and considering prophylactic hydrocortisone during critical illness 8